Article Information
History
- March 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ana I. Cubas-Atienzar1,*,
- Konstantina Kontogianni1,
- Thomas Edwards1,
- Dominic Wooding1,
- Kate Buist1,
- Caitlin R. Thompson1,
- Christopher T. Williams1,
- Edward I Patterson2,3,
- Grant Hughes2,
- Lisa Baldwin1,
- Camille Escadafal4,
- Jilian A. Sacks4 and
- Emily R. Adams1
- 1Liverpool School of Tropical Medicine, Centre for Drugs and Diagnostics, Liverpool, L3 5QA, UK
- 2Liverpool School of Tropical Medicine, Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Diseases, Liverpool, L3 5QA, UK
- 3Brock University, Department of Biological Sciences, St. Catharines, L2S 3A1, Canada
- 4FIND, Foundation for Innovative New Diagnostics, Geneva, Switzerland
- ↵*Address correspondence to Ana I Cubas Atienzar: ana.cubasatienzar{at}lstmed.ac.uk
Posted March 22, 2021.
Limit of detection in different matrices of nineteen commercially available rapid antigen tests for the detection of SARS-CoV-2
